Category Archives: selumetinib

Researchers map epigenetic pathway as target for therapy of aggressive pediatric brain cancer.


Working with cells taken from children with a very rare but aggressive form of brain cancer, Johns Hopkins University scientists have identified a genetic pathway that acts as a master regulator of thousands of other genes which spur cancer cell growth and resistance to anticancer treatment. AT/RT mostly strikes children 6 and younger, and the survival rate is less than

Read more